NONOF News and Press, Novo-Nordisk A/S From 10/01/23

2023-10-01 12:00:03 ET More on Novo Nordisk Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss Novo Nordisk: DCF Analysis Suggests Significant Undervaluation Novo Nordisk: Catching The Falling Knife Now Could Really Hurt Viatris a...

2023-09-29 15:00:25 ET Summary Viatris Inc.'s Q2 2023 earnings presentation notes that generic forms of NVO's Ozempic and Wegovy are under regulatory review. Despite newer therapies, older drugs like Trulicity continue to generate significant revenues, so a generic semaglutide cou...

2023-09-29 09:04:49 ET More on Structure Structure Therapeutics: Recent IPO With Large Valuation IPO Roundup: SharkNinja, Pixie Dust Technologies and more Best and worst performing healthcare IPOs of 2023, so far Historical earnings data for Structure Therape...

2023-09-28 12:21:56 ET More on Wave Life Sciences Wave Life Sciences: Excellent Early Data, Major Collaborations, Needs Cash Wave Life Sciences Ltd. (WVE) Q2 2023 Earnings Call Transcript Wave Life Sciences an outperform at Raymond James on RNA editing Seekin...

2023-09-25 09:52:52 ET More on Novo Nordisk Novo Nordisk: Catching The Falling Knife Now Could Really Hurt Novo Nordisk: What The Stock Split Means For Traders And Investors Novo Nordisk: Super Focused Pharma Company For The Long Run Novo Nordisk: Strong Fund...

2023-09-22 08:30:00 ET Summary Novo Nordisk shares reached all-time highs in September but have since dropped nearly 10%. Buyers must question whether peak optimism has been priced in. With an "F" valuation grade, it isn't the time to be aggressive unless robust buying sentiments ...

2023-09-20 13:38:19 ET More on Novo Novo Nordisk: What The Stock Split Means For Traders And Investors Novo Nordisk: Super Focused Pharma Company For The Long Run Novo Nordisk: Strong Fundamentals Meet Technical Uptrends Novo Nordisk facility in N.C. flagged ...

2023-09-20 11:53:19 ET Summary Danish diabetes care giant Novo Nordisk is splitting its shares, with the Danish-listed B shares splitting on September 13 and the NYSE-listed ADRs splitting on September 20. This split marks a milestone in Novo Nordisk's share price appreciation, as...

2023-09-19 15:36:22 ET More on Lilly Seeking Alpha’s Quant Rating on Eli Lilly Historical earnings data for Eli Lilly Dividend scorecard for Eli Lilly Eli Lilly: A Potential Game Changer For Weight Management And Cardiovascular Health Eli Lilly...

2023-09-16 08:26:36 ET Summary The sector as a whole is overvalued by about 15% relative to 11-year averages. Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. IXJ: a global alternative to ...